miR-1224-5p Enhances Hepatic Lipogenesis by Targeting Adenosine Monophosphate–Activated Protein Kinase α1 in Male Mice-Reference-Cited by-同舟云学术

miR-1224-5p Enhances Hepatic Lipogenesis by Targeting Adenosine Monophosphate–Activated Protein Kinase α1 in Male Mice

Published:2018-02-21 Issue:5 Volume:159 Page:2008-2021
ISSN:1945-7170
Container-title:Endocrinology
language:en
Short-container-title:

Author:

Chen Tianxing¹,Yan Dong²,Cheng Xiaoying¹,Ji XiaoJun¹,Bian Jinjun³,Yin Wu¹⁴⁵

Affiliation:

1. The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Sciences, Nanjing University, Nanjing, China

2. Department of Cardiology, Affiliated Hospital of Nanjing University of TCM, Nanjing, China

3. Department of Anesthesiology and Critical Care, Changhai Hospital, Second Military Medical University, Shanghai, China

4. Jiangsu Key Laboratory of Pediatric Respiratory Disease, Nanjing University of Chinese Medicine, Nanjing, China

5. Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China

Funder

Natural Science Fund of China

The Open Project of Jiangsu Key Laboratory of Pediatric Respiratory Disease

The Open Project Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica

Publisher

The Endocrine Society

Subject

Endocrinology

Link

http://academic.oup.com/endo/article-pdf/159/5/2008/24610003/en.2017-03231.pdf

Reference62 articles.

1. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008;Younossi;Clin Gastroenterol Hepatol,2011

2. Prevalence of nonalcoholic fatty liver disease (NAFLD) and disease severity among African Americans (AA) with prediabetes (preDM) or type 2 diabetes (T2DM);Bril;Diabetes,2014

3. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients;Targher;Diabetes,2005

4. Animal models in nonalcoholic steatohepatitis research: utility and clinical translation;Anstee;Liver Int,2011

5. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C;Yatsuji;J Gastroenterol Hepatol,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver disease;European Journal of Medical Research;2023-12-19

2. MicroRNA regulation of AMPK in nonalcoholic fatty liver disease;Experimental & Molecular Medicine;2023-09-01

3. GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis;Cell Death & Differentiation;2023-06-19

4. Therapeutic Effects of microRNAs on Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2023-05-23

5. Exosomes and lipid metabolism in metabolic and cardiovascular disorders;Current Opinion in Lipidology;2023-04